155 related articles for article (PubMed ID: 14526391)
1. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers.
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Am J Hum Genet; 2003 Nov; 73(5):1157-61. PubMed ID: 14526391
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.
Cravo M; Afonso AJ; Lage P; Albuquerque C; Maia L; Lacerda C; Fidalgo P; Chaves P; Cruz C; Nobre-Leitão C
Gut; 2002 Mar; 50(3):405-12. PubMed ID: 11839723
[TBL] [Abstract][Full Text] [Related]
3. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system.
Trojan J; Zeuzem S; Randolph A; Hemmerle C; Brieger A; Raedle J; Plotz G; Jiricny J; Marra G
Gastroenterology; 2002 Jan; 122(1):211-9. PubMed ID: 11781295
[TBL] [Abstract][Full Text] [Related]
5. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing.
Auclair J; Busine MP; Navarro C; Ruano E; Montmain G; Desseigne F; Saurin JC; Lasset C; Bonadona V; Giraud S; Puisieux A; Wang Q
Hum Mutat; 2006 Feb; 27(2):145-54. PubMed ID: 16395668
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.
Liu SR; Zhao B; Wang ZJ; Wan YL; Huang YT
World J Gastroenterol; 2004 Sep; 10(18):2647-51. PubMed ID: 15309712
[TBL] [Abstract][Full Text] [Related]
7. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
[TBL] [Abstract][Full Text] [Related]
8. [Mutation analysis of hMSH2 and hMLH1 genes in Chinese hereditary nonpolyposis colorectal cancer families].
Cai Q; Sun MH; Fu G; Ding CW; Mo SJ; Cai SJ; Ren SX; Min DL; Xu XL; Zhu WP; Zhang TM; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):323-8. PubMed ID: 14514376
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterization of Chinese hereditary non-polyposis colorectal cancer by DHPLC and multiplex PCR.
Yuan Y; Huang YQ; Cai SR; Song YM; Zheng S; Zhang SZ
Jpn J Clin Oncol; 2004 Nov; 34(11):660-6. PubMed ID: 15613555
[TBL] [Abstract][Full Text] [Related]
10. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
[TBL] [Abstract][Full Text] [Related]
11. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Weber TK; Chin HM; Rodriguez-Bigas M; Keitz B; Gilligan R; O'Malley L; Urf E; Diba N; Pazik J; Petrelli NJ
JAMA; 1999 Jun 23-30; 281(24):2316-20. PubMed ID: 10386556
[TBL] [Abstract][Full Text] [Related]
12. ASA E382K disrupts a potential exonic splicing enhancer and causes exon skipping, but missense mutations in ASA are not associated with ESEs.
Shotelersuk V; Desudchit T; Tongkobpetch S
Int J Mol Med; 2004 Oct; 14(4):683-9. PubMed ID: 15375602
[TBL] [Abstract][Full Text] [Related]
13. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.
Xinarianos G; Liloglou T; Prime W; Maloney P; Callaghan J; Fielding P; Gosney JR; Field JK
Cancer Res; 2000 Aug; 60(15):4216-21. PubMed ID: 10945633
[TBL] [Abstract][Full Text] [Related]
14. Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family.
McVety S; Li L; Gordon PH; Chong G; Foulkes WD
J Med Genet; 2006 Feb; 43(2):153-6. PubMed ID: 15923275
[TBL] [Abstract][Full Text] [Related]
15. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
Balogh GA; Russo IH; Russo J
Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
[TBL] [Abstract][Full Text] [Related]
16. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
[TBL] [Abstract][Full Text] [Related]
17. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang L; Cunningham JM; Winters JL; Guenther JC; French AJ; Boardman LA; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN
Cancer Res; 2003 Sep; 63(17):5209-12. PubMed ID: 14500346
[TBL] [Abstract][Full Text] [Related]
18. CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations.
Maliaka YK; Chudina AP; Belev NF; Alday P; Bochkov NP; Buerstedde JM
Hum Genet; 1996 Feb; 97(2):251-5. PubMed ID: 8566964
[TBL] [Abstract][Full Text] [Related]
19. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients.
Baudhuin LM; Ferber MJ; Winters JL; Steenblock KJ; Swanson RL; French AJ; Butz ML; Thibodeau SN
Gastroenterology; 2005 Sep; 129(3):846-54. PubMed ID: 16143124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
